Milestone Pharmaceuticals Inc. (MIST) Free cash flow 2018–2025
Milestone Pharmaceuticals Inc. (MIST) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$49.3MFY2025 · since FY2018: -$21.1M → -$49.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.3M | -70.8% |
| FY2024 | -$28.9M | +37.9% |
| FY2023 | -$46.5M | +11.8% |
| FY2022 | -$52.7M | — |
| FY2019 | -$51.6M | -145.0% |
| FY2018 | -$21.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MIST financial trends
MIST RevenueMIST Net incomeMIST Net marginMIST Gross profitMIST Gross marginMIST Operating incomeMIST Operating marginMIST Operating cash flowMIST Capital expendituresMIST Return on equityMIST Stock buybacksMIST Dividends paidMIST Total assetsMIST Total liabilitiesMIST Shareholders’ equityMIST overview →